These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5309476)

  • 21. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.
    Hurwitz ES; Haber M; Chang A; Shope T; Teo ST; Giesick JS; Ginsberg MM; Cox NJ
    J Infect Dis; 2000 Oct; 182(4):1218-21. PubMed ID: 10979921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.
    Levie K; Leroux-Roels I; Hoppenbrouwers K; Kervyn AD; Vandermeulen C; Forgus S; Leroux-Roels G; Pichon S; Kusters I
    J Infect Dis; 2008 Sep; 198(5):642-9. PubMed ID: 18576945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of influenza vaccine in the elderly.
    Neafsey PJ; Tyler C
    Home Healthc Nurse; 2005 Oct; 23(10):640-1. PubMed ID: 16217211
    [No Abstract]   [Full Text] [Related]  

  • 24. Bird flu vaccine.
    Environ Health Perspect; 1998 Jul; 106(7):A319. PubMed ID: 9735000
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
    Mamula P; Markowitz JE; Piccoli DA; Klimov A; Cohen L; Baldassano RN
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An outbreak of influenza B at an Indiana boarding school: estimate of vaccine efficacy.
    DeStefano F
    Public Health Rep; 1982; 97(3):269-72. PubMed ID: 7089171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.
    De Filette M; Ramne A; Birkett A; Lycke N; Löwenadler B; Min Jou W; Saelens X; Fiers W
    Vaccine; 2006 Jan; 24(5):544-51. PubMed ID: 16169634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adju-fluax.
    Drug Ther Bull; 1974 Sep; 12(20):79-80. PubMed ID: 4457299
    [No Abstract]   [Full Text] [Related]  

  • 30. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children.
    Hosai H; Omura S; Maeda A; Kunita N
    Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza.
    Swayne DE; Beck JR; Perdue ML; Beard CW
    Avian Dis; 2001; 45(2):355-65. PubMed ID: 11417815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Registration of the first human vaccine against the highly pathogenic avian influenza A(H5N1) virus: considerations].
    de Jong JC; Osterhaus AD
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2113-5. PubMed ID: 18856026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza control in the 21st century: Optimizing protection of older adults.
    Monto AS; Ansaldi F; Aspinall R; McElhaney JE; Montaño LF; Nichol KL; Puig-Barberà J; Schmitt J; Stephenson I
    Vaccine; 2009 Aug; 27(37):5043-53. PubMed ID: 19559118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protective effect of polyvalent oil-adjuvant influenza vaccine in chdren.
    Quilligan JJ; Baernstein HD
    Pediatrics; 1966 Aug; 38(2):207-10. PubMed ID: 5944155
    [No Abstract]   [Full Text] [Related]  

  • 35. A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.
    Tamura SI; Kurata T
    Jpn J Infect Dis; 2000 Jun; 53(3):98-106. PubMed ID: 10957706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre- or post-pandemic influenza vaccine?
    Osterhaus AD
    Vaccine; 2007 Jun; 25(27):4983-4. PubMed ID: 17555851
    [No Abstract]   [Full Text] [Related]  

  • 37. Hong Kong influenza.
    Andrewes C
    WHO Chron; 1970 Mar; 24(3):89-98. PubMed ID: 5439246
    [No Abstract]   [Full Text] [Related]  

  • 38. Improved design and intranasal delivery of an M2e-based human influenza A vaccine.
    De Filette M; Fiers W; Martens W; Birkett A; Ramne A; Löwenadler B; Lycke N; Jou WM; Saelens X
    Vaccine; 2006 Nov; 24(44-46):6597-601. PubMed ID: 16814430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study.
    Magnani G; Falchetti E; Pollini G; Reggiani LB; Grigioni F; Coccolo F; Potena L; Magelli C; Sambri V; Branzi A
    J Heart Lung Transplant; 2005 May; 24(5):588-92. PubMed ID: 15896757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.